A New Reality: The Synergy of AI & RWD

Paul recently established "Impatient Health", a cross between a think-tank, a consultancy and a design studio for pharma, with more than 25 clients looking to redesign how value can be created in life sciences. He is sometimes known as the ‘pharma provocateur’ for his role in provoking and rethinking business models. His industry journey started in June 2003 with ‘eyeforpharma’, an organisation which he quickly grew into the pharmaceutical industry’s most influential event organiser, acquired by Reuters in 2019. CEOs and disruptors regularly featured on Paul’s stages, especially at flagship events in Barcelona, Philadelphia, Tokyo and Sydney. Paul also devised and managed the only pharmaceutical award ceremony to focus on patient and healthcare value.

Paul has recently presented at companies including AstraZeneca, Roche, Merck, Leo, AbbVie, Abbott, Novo Nordisk, Sanofi and Takeda. He chairs approximately 20 webinars per year, each with audiences of between 500 and 2500. He has perhaps the largest contact book in the pharmaceutical industry, covering all major companies at C-level. Paul also co-founded The Aurora Project, a non-profit designed to make patient centricity more commonplace within pharmaceuticals. He is an Advisory Board member at Hu-manity.co and a Trustee at patient charity Fibro Flutters.